The Spot The Early Signs Program is independently developed and managed by EiP in terms of content, topics and speakers appointed. Unrestricted grants are sought to support EIP activities. Sanofi Genzyme and Orchard Therapeutics, among other organisations, have provided unrestricted educational grants to partially support EIP's work on the misdiagnosis of rare diseases.